As mentioned above, our findings are supported by several studies showing that renal fibrosis was attenuated by the pan-HDAC inhibitor TSA [57], class I HDAC inhibitor MS-275 [56], and HDAC6-selective inhibitor Tubastatin A [16]. This evidence concerns the gene HDAC6 and renal fibrosis.